Bright Eye Hospital Group Co., Ltd. (SHE:301239)
China · Delayed Price · Currency is CNY 34.94
-0.32 (-0.91%)
Feb 11, 2026, 4:00 PM EST
Bright Eye Hospital Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | -101.35 | -101.86 | 267.91 | 20.57 | 93.89 | 108.93 |
Depreciation & Amortization | 311.36 | 311.36 | 273.82 | 214.82 | 177.71 | 49.9 |
Other Amortization | 88.03 | 88.03 | 68.89 | 51.99 | 42.89 | 35.93 |
Loss (Gain) From Sale of Assets | 0.93 | 0.93 | -0.06 | -0.56 | -0.93 | -0.75 |
Asset Writedown & Restructuring Costs | 6 | 6 | 0.47 | 2.12 | 8.62 | 12.32 |
Loss (Gain) From Sale of Investments | 3.51 | 3.51 | -78.29 | -12.6 | -9.47 | -1.89 |
Provision & Write-off of Bad Debts | -0.22 | -0.22 | 3.37 | 1.59 | - | 2.25 |
Other Operating Activities | 97.32 | 98.18 | 88.57 | 60.4 | 52.47 | 2.45 |
Change in Accounts Receivable | 4.04 | 4.04 | -23.18 | -13.26 | -5.11 | -39.57 |
Change in Inventory | 2.28 | 2.28 | -45.68 | -18.95 | -12.18 | -12.26 |
Change in Accounts Payable | -24.32 | -24.32 | 63.97 | 18.09 | 13.41 | 70.43 |
Change in Other Net Operating Assets | - | - | -3.24 | - | 1.63 | - |
Operating Cash Flow | 382.08 | 382.43 | 614.46 | 319.3 | 359.42 | 227.51 |
Operating Cash Flow Growth | -20.52% | -37.76% | 92.44% | -11.16% | 57.98% | 117.02% |
Capital Expenditures | -222.98 | -542.86 | -626.87 | -327.99 | -254.8 | -146.6 |
Sale of Property, Plant & Equipment | 1.93 | 1.45 | 0.22 | 1.02 | 1.76 | 3.43 |
Cash Acquisitions | -12.94 | -5 | 88.53 | - | -168.7 | - |
Investment in Securities | -8.05 | -8.63 | -29.24 | -274.91 | -7.6 | 50.85 |
Other Investing Activities | 1.6 | 1.66 | -1.02 | - | - | -1 |
Investing Cash Flow | -240.45 | -553.38 | -568.38 | -601.88 | -429.47 | -94.34 |
Short-Term Debt Issued | - | - | - | - | - | 0.4 |
Long-Term Debt Issued | - | 550.13 | 282.8 | 202.5 | 110 | - |
Total Debt Issued | 151.29 | 550.13 | 282.8 | 202.5 | 110 | 0.4 |
Short-Term Debt Repaid | - | - | - | - | -0.58 | -0.4 |
Long-Term Debt Repaid | - | -579.31 | -391.52 | -259.13 | -149.15 | -2.16 |
Total Debt Repaid | -353.81 | -579.31 | -391.52 | -259.13 | -149.73 | -2.56 |
Net Debt Issued (Repaid) | -202.52 | -29.18 | -108.72 | -56.63 | -39.73 | -2.16 |
Issuance of Common Stock | - | - | - | 1,152 | - | - |
Repurchase of Common Stock | -29.8 | -29.8 | -29.98 | - | - | - |
Common Dividends Paid | -28.5 | -77.97 | -27.63 | -9.04 | -4.55 | -1.23 |
Other Financing Activities | 15.41 | -17.82 | - | -47.94 | - | - |
Financing Cash Flow | -245.42 | -154.78 | -166.33 | 1,038 | -44.28 | -3.38 |
Foreign Exchange Rate Adjustments | 0.1 | 0.1 | -0.41 | -0.29 | -0 | - |
Net Cash Flow | -103.68 | -325.63 | -120.65 | 755.46 | -114.33 | 129.79 |
Free Cash Flow | 159.1 | -160.43 | -12.41 | -8.68 | 104.62 | 80.91 |
Free Cash Flow Growth | - | - | - | - | 29.30% | - |
Free Cash Flow Margin | 5.80% | -5.99% | -0.46% | -0.50% | 6.12% | 5.94% |
Free Cash Flow Per Share | 1.04 | -1.07 | -0.08 | -0.07 | 0.94 | 0.72 |
Cash Income Tax Paid | 94.07 | 139.54 | 96.41 | 58.08 | 65.41 | 47.45 |
Levered Free Cash Flow | 148.79 | -216.59 | 78.63 | 1.6 | 66.15 | 34.37 |
Unlevered Free Cash Flow | 203.13 | -162.16 | 125.29 | 37.58 | 96.43 | 35.4 |
Change in Working Capital | -23.5 | -23.5 | -10.23 | -19.03 | -5.76 | 18.36 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.